Brief: Aptorum Therapeutics Ltd Enters Into Letter Of Intent And Term Sheet With Universal Sequencing Technology Corp To Merge With Aptorum Group's Subsidiary Paths Innovations Ltd
May 1 (Reuters) - Aptorum Group Ltd APM.O :
* APTORUM THERAPEUTICS LIMITED ENTERS INTO LETTER OF INTENT
AND
TERM SHEET WITH UNIVERSAL SEQUENCING TECHNOLOGY CORPORATION TO
MERGE WITH APTORUM GROUP’S SUBSIDIARY PATHS INNOVATIONS LIMITED
* APTORUM GROUP LTD-AS CONSIDERATION OF TRANSACTION UPON
CLOSING,
CO'S UNIT APTORUM THERAPEUTICS LIMITED WILL BECOME SHAREHOLDER
OF COMBINED CO
Source text for Eikon: ID:nBw893cda
Further company coverage: APM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aptorum
See all newsBrief: Niki Biosolutions Signs Agreement To Supply Apoe Genotyping To Charter Research
NASDAQ RESUMED AT 10:24 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:19 AM
Niki BioSolutions weighs financing options as going-concern warning clouds post-merger outlook
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM